Although HIF-1 has been reported to have both beneficial and pathological roles in experimental atherosclerosis, genetic and pharmacological inhibition of PHD protects against the development of atherosclerosis in high-fat-diet-fed LDL receptor-deficient mice [29]. Here, PDC is linked to atherosclerosis.